Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing 76 - 100 of 259
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, CNS Tumors Trial in Trondheim (18F-FDG, 18F-fluciclovine, standard MRI)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Central Nervous System Neoplasms
  • 18F-FDG
  • +2 more
  • Trondheim, Norway
    Norwegian University of Science and Technology, Department of Ci
Dec 15, 2021

Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

Active, not recruiting
  • Lymphoma
  • +3 more
  • TGFbeta resistant LMP-specific CTLs
  • Houston, Texas
  • +1 more
Dec 8, 2021

Lymphoma, Non-Hodgkin Trial in Worldwide (Nivolumab, Rituximab, Gemcitabine)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Feldkirch, Austria
  • +78 more
Nov 18, 2021

Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin Trial in Birmingham (Siltuximab)

Recruiting
  • Cytokine Release Syndrome
  • +4 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 17, 2021

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +21 more
Oct 26, 2021

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +13 more
Oct 27, 2021

Lymphoma, Non-Hodgkin, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +8 more
  • Los Angeles, California
    USC CRS
Oct 26, 2021

Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

Completed
Has Results
  • Lymphoma, B-Cell
  • +2 more
  • Autologous transplantation using rituxan/BEAM
  • Autologous transplantation using Bexxar/BEAM
  • New Haven, Connecticut
  • +35 more
Oct 21, 2021

Hematologic Malignancy, Leukemia, Lymphoma Trial in Boston (CAR-37 T cells)

Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 28, 2021

Lymphoma, Non-Hodgkin, HIV Trial in New Orleans (Methotrexate, Leucovorin calcium, Zidovudine)

Terminated
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • New Orleans, Louisiana
    Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU
Oct 27, 2021

Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

Completed
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Sep 16, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Marginal Zone Trial in Nagoya-shi, Chuo-ku, Seoul (TAK-659)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Lymphoma, Follicular, Marginal Zone
  • Nagoya-shi, Aichi, Japan
  • +3 more
Aug 17, 2021

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

Terminated
  • Leukemia, Myeloid, Acute
  • +8 more
  • Mesenchymal stem cells
  • Isotonic solution
  • Edeghem, Antwerpen, Belgium
  • +9 more
Aug 31, 2021

Family Study of Lymphoproliferative Disorders

Recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Aug 30, 2021

    Lymphoma Epidemiology of Outcomes Cohort Years 6-10

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
      • Miami, Florida
      • +7 more
      Aug 20, 2021

      Lymphoma, Non-Hodgkin, Lymphoma, Large B-cell, Diffuse, Lymphoma, Follicular Trial in Canada, Germany, United States (TAK-659,

      Completed
      • Lymphoma, Non-Hodgkin
      • +2 more
      • Birmingham, Alabama
      • +14 more
      Aug 23, 2021

      Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

      Recruiting
      • Myeloid Leukemia, Chronic
      • +8 more
      • Conventional T cells (Tcon) and Regulatory T cells (Treg)
      • Palo Alto, California
        Stanford University School of Medicine Palo Alto, California, Un
      Aug 18, 2021

      NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

      Completed
      • NHL
      • +17 more
      • veltuzumab
      • Savannah, Georgia
      • +4 more
      Aug 12, 2021

      Granulocyte Colony Stimulating Factor Originator Products Versus

      Active, not recruiting
      • Cancer, Breast
      • +5 more
      • Receipt of granulocyte-colony stimulating factor
      • (no location specified)
      Jul 24, 2021

      Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,

      Active, not recruiting
      • Lymphoma, Non-Hodgkin
      • Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
      • Vancouver, British Columbia, Canada
        BC Cancer Agency
      Jul 20, 2021

      Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

      Enrolling by invitation
      • Monoclonal Gammopathy of Undetermined Significance
      • +6 more
        • Milwaukee, Wisconsin
          Aurora Health Care
        Jul 20, 2021

        Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

        Active, not recruiting
        • Lymphoma, Non-Hodgkin
        • +5 more
        • Providence, Rhode Island
          Rhode Island Hospital and The Miriam Hospital
        Jul 19, 2021

        Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)

        Terminated
        Has Results
        • Hodgkin Disease
        • Lymphoma, Non-hodgkin
        • New York, New York
          Columbia University Irving Medical Center - Center for Lymphoid
        Jun 28, 2021

        Ascertainment of Peripheral Blood or Saliva Samples for Genetic

        Active, not recruiting
        • Breast Neoplasms
        • +6 more
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Jun 14, 2021

          Lymphoma, Non-Hodgkin Trial in Beijing (Copanlisib (Aliqopa, BAY80-6946))

          Completed
          • Lymphoma, Non-Hodgkin
          • Copanlisib (Aliqopa, BAY80-6946)
          • Beijing, China
            Beijing Cancer Hospital
          May 17, 2021